Patents Assigned to Replidyne, Inc.
-
Patent number: 8716320Abstract: The present invention provides novel heterocyclic urea compounds having useful antibacterial activity, pharmaceutical compositions comprising one or more of these compounds, methods of making the same, and methods of using the same.Type: GrantFiled: July 23, 2007Date of Patent: May 6, 2014Assignee: Replidyne, Inc.Inventors: Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun
-
Publication number: 20100028862Abstract: Reconstituted bacterial replication assemblies and methods for their use are provided.Type: ApplicationFiled: April 26, 2005Publication date: February 4, 2010Applicant: Replidyne,Inc.Inventors: Thale Cross Jarvis, Charles S. McHenry, Nebojsa Janjic, Garry Dallmann, James M. Bullard, Stacie Bell, Glenn Sanders, Frank Dean
-
Publication number: 20090163536Abstract: Methionyl tRNA synthetase inhibitors (MetRS) are provided for use in therapy as antibacterial agents in Clostridium based infection.Type: ApplicationFiled: September 11, 2007Publication date: June 25, 2009Applicant: REPLIDYNE, INC.Inventors: JOSEPH GUILES, XICHENG SUN, NEBOJSA JANJIC, SARAH STRONG
-
Publication number: 20090092592Abstract: The invention provides metS polypeptides and DNA (RNA) encoding metS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing metS polypeptides to screen for antibacterial compounds.Type: ApplicationFiled: October 19, 2007Publication date: April 9, 2009Applicant: REPLIDYNE, INC.Inventor: Elizabeth Jane Lawlor
-
Publication number: 20090054667Abstract: Methods for introducing a 1-halo-1-haloalkene compound onto an aromatic or heteroaromatic ring are provided, including processes for the production of certain 1-halovinyl aryl or heteroaryl derivatives in which the 1-halovinyl group is either 1-fluoro or 1-chlorovinyl and the aromatic species phenyl or thiophene, the processes including coupling an arylmagnesium species with a dihalo olefin in the presence of a nickel or iron catalyst.Type: ApplicationFiled: August 9, 2006Publication date: February 26, 2009Applicant: Replidyne, Inc.Inventors: Joseph W. Guiles, Jian Qiu, Theodore M. Tarasow
-
Publication number: 20080227808Abstract: Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side phenylether constituent and a right hand side thienopyridone constituent. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-Clostridium difficile agents.Type: ApplicationFiled: September 11, 2007Publication date: September 18, 2008Applicant: REPLIDYNE, INC.Inventors: JOSEPH GUILES, XICHENG SUN, NEBOJSA JANJIC, SARAH STRONG
-
Publication number: 20080207703Abstract: The present invention provides novel heterocyclic urea compounds having useful antibacterial activity, pharmaceutical compositions comprising one or more of these compounds, methods of making the same, and methods of using the same.Type: ApplicationFiled: July 23, 2007Publication date: August 28, 2008Applicant: Replidyne, Inc.Inventors: Joseph Guiles, Thale Jarvis, Sarah Strong, Xicheng Sun
-
Publication number: 20080194842Abstract: Methods for introducing a 1-halo-1-haloalkene compound onto an aromatic or heteroaromatic ring are provided, including processes for the production of certain 1-halovinyl aryl or heteroaryl derivatives in which the 1-halovinyl group is either 1-fluoro or 1-chlorovinyl and the aromatic species phenyl or thiophene, the processes including coupling an arylmagnesium species with a dihalo olefin in the presence of a nickel or iron catalyst.Type: ApplicationFiled: August 9, 2006Publication date: August 14, 2008Applicant: REPLIDYNE, INC.Inventors: Joseph W. Guiles, Jian Qiu, Theodore M. Tarasow
-
Publication number: 20080146609Abstract: Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side chroman group or left hand side tetrahydroquinoline group and a right hand side thienopyridone group. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, particularly as anti-Clostridium difficile agents.Type: ApplicationFiled: September 11, 2007Publication date: June 19, 2008Applicant: REPLIDYNE, INC.Inventors: Joseph GUILES, Xicheng SUN, Nebojsa JANJIC, Sarah STRONG
-
Publication number: 20080138835Abstract: Mutant bacterial MRS nucleic acids and proteins are provided, as well as uses for the nucleic acids and proteins, such as in a high-throughput screen for inhibitors of the mutant proteins.Type: ApplicationFiled: May 9, 2005Publication date: June 12, 2008Applicant: REPLIDYNE, INC.Inventors: Ian A. Critchley, Urs Ochsner, James M. Bullard
-
Publication number: 20080124313Abstract: The invention provides tRNA synthetase polypeptides and DNA (RNA) encoding tRNA synthetase polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing tRNA synthetase polypeptide for the protection against infection, particularly bacterial infections.Type: ApplicationFiled: December 10, 2007Publication date: May 29, 2008Applicant: REPLIDYNE, INC.Inventors: JOHN EDWARD HODGSON, ELIZABETH JANE LAWLOR
-
Publication number: 20080108651Abstract: Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for Clostridium difficile infection.Type: ApplicationFiled: September 11, 2007Publication date: May 8, 2008Applicant: REPLIDYNE, INC.Inventors: Joseph GUILES, Xicheng SUN, Nebojsa JANJIC, Sarah STRONG, Albert GYORKOS
-
Patent number: 7361476Abstract: The invention provides metS polypeptides and DNA (RNA) encoding metS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing metS polypeptides to screen for antibacterial compounds.Type: GrantFiled: June 28, 2005Date of Patent: April 22, 2008Assignee: Replidyne, Inc.Inventor: Elizabeth Jane Lawlor
-
Patent number: 7335499Abstract: The invention provides tRNA synthetase polypeptides and DNA (RNA) encoding tRNA synthetase polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing tRNA synthetase polypeptide for the protection against infection, particularly bacterial infections.Type: GrantFiled: January 24, 2006Date of Patent: February 26, 2008Assignee: Replidyne, Inc.Inventors: John Edward Hodgson, Elizabeth Jane Lawlor
-
Publication number: 20070292921Abstract: The invention relates to metRS polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques. Also disclosed are methods for utilizing metRS polypeptides and polynucleotides in diagnostic assays.Type: ApplicationFiled: August 2, 2006Publication date: December 20, 2007Applicant: Replidyne, Inc.Inventors: Philip Hayes, Daniel Gentry, Stephanie Van Horn
-
Patent number: 7304152Abstract: The invention provides metRS2 polypeptides and polynucleotides encoding metRS2 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing metRS2 polypeptides and polynucleotides as diagnostic reagents and in diagnostic assays to screen for microbial infections in organisms and infections in materials.Type: GrantFiled: June 16, 2006Date of Patent: December 4, 2007Assignee: Replidyne, Inc.Inventors: Daniel R Gentry, David J Holmes, Karen A Ingraham
-
Publication number: 20070213362Abstract: A method of inhibiting MetRS activity comprises administering to a patient in need thereof a MetRS inhibiting effective amount of a compound of the formula (I). A method of treating a resistant or multiply-resistant E. faecalis infection, a resistant or multiply-resistant S. aureus infection, and/or a resistant or multiply-resistant S. epidermidis infection comprises administering to a patient in need thereof an antibacterially effective amount of a compound of the formula (I).Type: ApplicationFiled: May 21, 2007Publication date: September 13, 2007Applicant: Replidyne, Inc.Inventors: John Berge, Andrew Forrest, Dieter Hamprecht, Richard Jarvest
-
Patent number: 7220757Abstract: Compounds of formula (I): are inhibitors of bacterial methionyl tRNA synthetase and are of use in treating bacterial infections.Type: GrantFiled: September 9, 2005Date of Patent: May 22, 2007Assignee: Replidyne, Inc.Inventors: John Berge, Andrew Forrest, Dieter Hamprecht, Richard Jarvest
-
Publication number: 20070009993Abstract: The invention provides metRS2 polypeptides and polynucleotides encoding metRS2 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing metRS2 polypeptides and polynucleotides as diagnostic reagents and in diagnostic assays to screen for microbial infections in organisms and infections in materials.Type: ApplicationFiled: June 16, 2006Publication date: January 11, 2007Applicant: Replidyne, Inc.Inventors: Daniel Gentry, David Holmes, Karen Ingraham
-
Patent number: 7128920Abstract: The invention provides metRS2 polypeptides and polynucleotides encoding metRS2 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing metRS2 polypeptides and polynucleotides as diagnostic reagents and in diagnostic assays to screen for microbial infections in organisms and infestations in materials.Type: GrantFiled: June 30, 2003Date of Patent: October 31, 2006Assignee: Replidyne, Inc.Inventors: Daniel R Gentry, David J Holmes, Karen A Ingraham